Accurate detection of the tumor clone in peripheral T-cell lymphoma biopsies by flow cytometric analysis of TCR-VΒ repertoire

Modern Pathology

Volumn 25, Issue 9, 2012, Pages 1246-1257

  Salameire, Dimitri ^a,b,c   Solly, Françoise ^a,b,c   Fabre, Blandine ^b,c   Lefebvre, Christine ^b,c   Chauvet, Martine ^b,c   Gressin, Rémy ^b,c   Corront, Bernadette ^d   Ciapa, Agnès ^e   Pernollet, Martine ^b,c   Plumas, Joël ^a,b,f   MacIntyre, Elizabeth ^g   Callanan, Mary B ^b,c   Leroux, Dominique ^a,b,c   Jacob, Marie Christine ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c HÔPITAL MICHALLON   (France)

^d CH de la Région d'Annecy   (France)

^e Histopathology Laboratory   (France)

^f ETABLISSEMENT FRANÇAIS DU SANG   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

flow cytometry; immunophenotype; T cell clonality; T cell lymphoma; TCR Vb repertoire

Indexed keywords

CD103 ANTIGEN; CD7 ANTIGEN; T CELL RECEPTOR V BETA; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE CLONE; MALE; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEZARY SYNDROME; T CELL LEUKEMIA; TUMOR BIOPSY;

EID: 84865720178     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.74     Document Type: Article

References (39)

1. Jaffe ES. Pathobiology of peripheral T-cell lymphomas. Hematol Am Soc Hematol Educ Program 2006;1: 317-322.
2. de Leval L, Gaulard P. Pathobiology and molecular profiling of peripheral T-cell lymphomas. Hematol Am Soc Hematol Educ Program 2008;1:272-279.
3. Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008;26:4124-4130.
4. Theodorou I, Delfau-Larue MH, Bigorgne C, et al. Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. Blood 1995;86:305-310.
5. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17: 2257-2317.
6. Bruggemann M, White H, Gaulard P, et al. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies. Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia 2007;21:215-221.
7. Theodorou I, Bigorgne C, Delfau MH, et al. VJ rearrangements of the TCR gamma locus in peripheral T-cell lymphomas: analysis by polymerase chain reaction and denaturing gradient gel electrophoresis. J Pathol 1996;178:303-310.
8. Droese J, Langerak AW, Groenen PJ, et al. Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies. Leukemia 2004;18:1531-1538.
9. Attygalle AD, Chuang SS, Diss TC, et al. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology 2007;50:498-508.
10. Cairns SM, Taylor JM, Gould PR, et al. Comparative evaluation of PCR-based methods for the assessment of T cell clonality in the diagnosis of T cell lymphoma. Pathology 2002;34:320-325.
11. Lima M, Almeida J, Santos AH, et al. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol 2001;159:1861-1868.
12. Feng B, Jorgensen JL, Jones D, et al. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sezary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging. Mod Pathol 2010;23:284-295.
13. Beck RC, Stahl S, O'Keefe CL, et al. Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies. Am J Clin Pathol 2003;120:785-794.
14. Morice WG, Kimlinger T, Katzmann JA, et al. Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques. Am J Clin Pathol 2004;121: 373-383.
15. Langerak AW, van Den Beemd R, Wolvers-Tettero IL, et al. Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood 2001;98:165-173.
16. Vonderheid EC, Boselli CM, Conroy M, et al. Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma. J Invest Dermatol 2005; 124:651-661.
17. Delfau-Larue MH, Laroche L, Wechsler J, et al. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 2000;96:2987-2992.
18. Posnett DN, Sinha R, Kabak S, et al. Clonal populations of T cells in normal elderly humans: the T cell equivalent to 'benign monoclonal gammapathy'. J Exp Med 1994;179:609-618.
19. Lima M, Teixeira Mdos A, Queiros ML, et al. Immunophenotype and TCR-Vbeta repertoire of peripheral blood T-cells in acute infectious mononucleosis. Blood Cells Mol Dis 2003;30:1-12.
20. Lin MT, Chang HM, Huang CJ, et al. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis. J Clin Pathol 2007;60:101-103.
21. Salameire D, Le Bris Y, Fabre B, et al. Efficient characterization of the TCR repertoire in lymph nodes by flow cytometry. Cytometry A 2009;75:743-751.
22. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn, vol 2. IARC: Lyon, 2008.
23. Jamal S, Picker LJ, Aquino DB, et al. Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. Am J Clin Pathol 2001;116:512-526.
24. Gorczyca W, Weisberger J, Liu Z, et al. An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry 2002;50:177-190.
25. Weisberger J, Cornfield D, Gorczyca W, et al. Downregulation of pan-T-cell antigens, particularly CD7, in acute infectious mononucleosis. Am J Clin Pathol 2003;120:49-55.
26. Lee SS, Rudiger T, Odenwald T, et al. Angioimmunoblastic T cell lymphoma is derived from mature Thelper cells with varying expression and loss of detectable CD4. Int J Cancer 2003;103:12-20.
27. Lefebvre C, Fabre B, Vettier C, et al. Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones. Hum Pathol 2007;38:660-667.
28. Delabesse E, Burtin ML, Millien C, et al. Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations. Leukemia 2000;14:1143-1152.
29. Langerak AW, Molina TJ, Lavender FL, et al. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2007;21:222-229.
30. Derniame S, Vignaud JM, Faure GC, et al. Comparative T-cell oligoclonality in lung, tumor and lymph nodes in human non-small cell lung cancer. Oncol Rep 2005;13:509-515.
31. Ramzaoui S, Jouen-Beades F, Michot F, et al. Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patients. Clin Exp Immunol 1995;99:182-188.
32. Tan BT, Warnke RA, Arber DA. The frequency of B-and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn 2006;8:466-475; quiz 527.
33. Geissinger E, Bonzheim I, Krenacs L, et al. Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies. J Mol Diagn 2005;7:455-464.
34. Dummer R, Nestle FO, Niederer E, et al. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7-T lymphocyte subsets in Sezary syndrome. Arch Dermatol Res 1999;291:307-311.
35. Washington LT, Huh YO, Powers LC, et al. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol 2002;2:5.
36. Koh HS, Lee C, Lee KS, et al. Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells. Mol Cells 2009;28:553-558.
37. Tembhare P, Yuan CM, Morris JC, et al. Flow cytometric immunophenotypic assessment of T-cell clonality by vbeta repertoire analysis in fine-needle aspirates and cerebrospinal fluid. Am J Clin Pathol 2010;137:220-226.
38. Dunleavy K, Wilson WH, Jaffe ES. Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr Opin Hematol 2007;14:348-353.
39. Rodriguez-Caballero A, Garcia-Montero AC, Barcena P, et al. Expanded cells in monoclonal TCR-alphabeta +CD4 +NKa +CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens. Blood 2008;112:4609-4616.